Aestus Therapeutics Inc. and Prosidion Limited (OSIP) Sign License Agreement for Novel Chronic Pain Therapeutic
9/19/2011 9:46:52 AM
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Announces Acquisition Of All Minority Interest Shares Of Prosidion Limited, (OSIP) UK-Based Diabetes And Obesity Subsidiary
10/19/2005 5:12:43 PM
More...
|
OSI Pharmaceuticals, Inc.'s (OSIP) Diabetes And Obesity Subsidiary, Prosidion Limited, (OSIP) Initiates Phase II Study With The DP-IV Inhibitor PSN9301
10/19/2005 5:12:24 PM
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Announces Issuance Of US Patent Covering Combination Therapy Using Dipeptidyl Peptidase IV -DPIV- Inhibitors And Other Antidiabetic Agents; Patent Licensed To OSI's UK Subsidiary Prosidion Limited
10/19/2005 5:10:20 PM
More...
|